A Review of Topical Corticosteroid Foams
August 2019
in “
PubMed
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → topical corticosteroid foams clobetasol propionate foam betamethasone valerate foam calcipotriol plus betamethasone dipropionate foam desonide 0.05% foam alopecia areata scalp psoriasis plaque-type psoriasis pediatric atopic dermatitis clobetasol foam betamethasone foam calcipotriol and betamethasone foam desonide foam
Studysummary This study found that topical corticosteroid foams are effective and generally preferred by patients for a variety of corticosteroid-responsive skin conditions, demonstrating significant clinical benefits such as improved psoriasis symptoms and hair regrowth in alopecia areata compared to traditional forms. Our plain-language summary of this paper — not a Tressless recommendation.
The review evaluated the efficacy and safety of topical corticosteroid foams for various dermatoses. It found that clobetasol propionate foam significantly improved moderate plaque-type psoriasis, with 68% of subjects achieving a favorable score compared to 21% in the control group. Betamethasone valerate (BMV) foam showed promising results for alopecia areata, with 42.86% of subjects achieving ≥75% hair regrowth, and was effective for scalp psoriasis. Calcipotriol plus betamethasone dipropionate foam and desonide 0.05% foam also demonstrated superior outcomes compared to their respective placebos. The study concluded that these foams are generally easy to apply, potentially improving patient adherence and clinical outcomes.
